HIV: Injectable PrEP Receives Approval
By Sharon Atieno Cabotegravir (CAB-LA),the first injectable form of HIV pre-exposure prophylaxis (PrEP), joins a wide range of HIV prevention tools including male and female condoms, daily oral PrEP, voluntary medical male circumcision (VMMC) and the Dapivirine Vaginal Ring after receiving the US Food and Drug Administration (FDA) approval. The CAB-LA, branded Apretude, is an […]